EyeOP

Glaucoma Diagnosis Procedure

Health Tech & Life Sciences
Non Active, Jun 2016
Pre-Funding Kiryat Ono, Israel Founded 2012
Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2012
Headcount
6
HQ
Kiryat Ono, Israel
Sector
Health Tech & Life Sciences

About

EyeOP offers amethod for intraocular pressure (IOP) measurement whenpatients are lying down. IOP measurement in the lying down position considerably improves the diagnostic ability and the timely, suitable treatment of glaucoma. The EyeOP system is comprised of a modified ophthalmic surgical bed with a slit lamp and headrest, enabling IOP measurement using a Goldmann applanation tonometer (GAT). An alternative configuration includesa cart for dual IOP-GAT measurement in sitting and lying down positions.

Q&A

What is EyeOP's primary business?
EyeOP offers a method and system for intraocular pressure (IOP) measurement when patients are lying down, which improves the diagnostic ability and treatment of glaucoma.
What is the current status of EyeOP?
EyeOP is currently inactive, with its status changed in June 2016.
When was EyeOP founded?
EyeOP was founded in January 2012.
What is EyeOP's primary sector?
EyeOP's primary sector is Health Tech & Life Sciences.
Who are the co-founders of EyeOP?
The co-founders of EyeOP are Vadim Shmukler and Nir Israeli.
What is the product stage of EyeOP's offering?
EyeOP's product is in the clinical trial stage.

Team · 2

Vadim Shmukler
Founder · Co-Founder
Nir Israeli
Founder · Co-Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

ophthalmologymedical-devicesglaucomadoctorsnon-invasiveclinicsmeasurementsdiagnostics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)